CLINICAL_TRIALS
trial_result
· 2024-12-20
Clinical Trial Update: Phase 4 COPD and Suboptimal Inspiratory Flow Rate [Phase 4]
Summary
Phase 4 COPD trial update examining the impact of suboptimal inspiratory flow rate, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theravance Biopharma | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2024-12-20